Next Article in Journal
Rate of Dental Extractions in Patients with Sickle Cell Disease
Next Article in Special Issue
Therapeutic Drug Monitoring of Infliximab in Acute Severe Ulcerative Colitis
Previous Article in Journal
Associations of the Alpha-Actinin Three Genotype with Bone and Muscle Mass Loss among Middle-Aged and Older Adults
Previous Article in Special Issue
Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases
 
 
Review

Article Versions Notes

J. Clin. Med. 2022, 11(20), 6173; https://doi.org/10.3390/jcm11206173
Action Date Notes Link
article pdf uploaded. 19 October 2022 15:31 CEST Version of Record https://www.mdpi.com/2077-0383/11/20/6173/pdf-vor
article xml file uploaded 25 October 2022 13:18 CEST Original file -
article xml uploaded. 25 October 2022 13:18 CEST Update https://www.mdpi.com/2077-0383/11/20/6173/xml
article pdf uploaded. 25 October 2022 13:18 CEST Updated version of record https://www.mdpi.com/2077-0383/11/20/6173/pdf
article html file updated 25 October 2022 14:01 CEST Original file -
article html file updated 28 February 2023 18:56 CET Update -
article html file updated 1 March 2023 23:00 CET Update https://www.mdpi.com/2077-0383/11/20/6173/html
Back to TopTop